Description

A person who injects an oral medication is at risk for developing an embolic retinopathy associated with a filler used for the medication. This is often talc but other materials may also be involved. This could be termed “retinopathy medicamentosa”.


 

The typical patient is an intravenous drug abuser who injects a liquid prepared from an oral tablet. This was initially described with oral methadone tablets..

 

Risk factors for talc retinopathy:

(1) repeated injections (Murphy et al report injection of 9,000 tablets or more)

(2) failure to completely solubilize the medicine and to filter the liquid

(3) some sort of right-to-left shunt

 

The material is often inert and insoluble (why it was chosen as a pharmaceutical filler) so can persist for years after the abuse has stopped.

 

Examination of the fundus will show deposits that are irregularly shaped and refractile.

 

If a deposit can be retrieved then it can be submitted for analysis if the specialized resources are available.

 

A patient with talc retinopathy is also at risk for:

(1) pulmonary talcosis (with interstitial fibrosis)

(2) microembolization to the brain, kidney, heart and/or digits

 

Differential diagnosis:

(1) bacterial endocarditis

 


To read more or access our algorithms and calculators, please log in or register.